What are Ultragenyx Pharmaceutical's profit margins?

Ultragenyx Pharmaceutical (RARE) runs a 97.2% gross margin and a -83.8% operating margin, with a -90.9% net margin.

Where do Ultragenyx Pharmaceutical's ratios come from?

Every ratio is computed from Ultragenyx Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Ultragenyx Pharmaceutical RARE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-79.5%+16.2pp	-95.7%+35.4pp	-131.1%+47.5pp	-178.6%-70.0pp
Net margin	-85.5%+16.1pp	-101.6%+38.3pp	-139.9%+54.8pp	-194.7%-65.5pp
EBITDA margin	-74.3%+15.0pp	-89.3%+35.8pp	-125.1%+48.5pp	-173.6%-68.7pp
Free cash flow margin	-70.2%+5.0pp	-75.2%+44.4pp	-119.6%+17.1pp	-136.7%-19.5pp
Returns
Return on assets	-37.9%+0.1pp	-38%+2.0pp	-40%+6.1pp	-46.1%-18.5pp
Efficiency
Asset turnover	0.4×+0.1×	0.4×+0.1×	0.3×0.0×	0.2×0.0×
Liquidity
Current ratio	2.5×+0.1×	2.4×-0.2×	2.6×-0.8×	3.4×-1.3×
Quick ratio	2.3×+0.1×	2.2×-0.2×	2.5×-0.8×	3.3×-1.4×
Cash ratio	1.1×+0.6×	0.5×-0.3×	0.8×+0.3×	0.5×-1.2×
Leverage
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	-$0.81-129%	$2.82-24.7%	$3.74-25.7%	$5.03-63.0%
Valuation
Market capitalization	$2.22B-42.9%	$3.88B+0.2%	$3.88B+19.4%	$3.25B-43.3%
Enterprise value	$1.83B-51.1%	$3.75B+1.2%	$3.71B+17.8%	$3.15B-42.4%
Price / sales	3.3×-3.6×	6.9×-2.0×	8.9×0.0×	8.9×-7.4×
EV / sales	2.7×-4.0×	6.7×-1.8×	8.5×-0.1×	8.7×-6.9×
Free cash flow yield	-21.3%-10.4pp	-10.8%+2.5pp	-13.4%+1.9pp	-15.3%-8.1pp
Earnings yield	-25.9%-11.3pp	-14.6%+1.0pp	-15.6%+6.1pp	-21.8%-13.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ultragenyx Pharmaceutical's profit margins?: Ultragenyx Pharmaceutical (RARE) runs a 97.2% gross margin and a -83.8% operating margin, with a -90.9% net margin.
Where do Ultragenyx Pharmaceutical's ratios come from?: Every ratio is computed from Ultragenyx Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.